A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

N Fazio; R Buzzoni; E Baudin; L Antonuzzo; R A Hubner; H Lahner; W.W. de Herder; M Raderer; A Teule; J Capdevila; SK Libutti; MH Kulke; M Shah; D Dey; S Turri; P Aimone; C Massacesi; C Verslype

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

N Fazio
, R Buzzoni
, E Baudin
, L Antonuzzo
, R A Hubner
, H Lahner
, W.W. de Herder
, M Raderer
, A Teule
, J Capdevila
, SK Libutti
, MH Kulke
, M Shah
, D Dey
, S Turri
, P Aimone
, C Massacesi
, C Verslype

Internal Medicine

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

82 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	713-719
Number of pages	7
Journal	Anticancer Research
Volume	36
Issue number	2
Publication status	Published - 2016

Research programs

EMC MM-01-39-01

Cite this

Fazio, N., Buzzoni, R., Baudin, E., Antonuzzo, L., Hubner, R. A., Lahner, H., de Herder, W. W., Raderer, M., Teule, A., Capdevila, J., Libutti, SK., Kulke, MH., Shah, M., Dey, D., Turri, S., Aimone, P., Massacesi, C., & Verslype, C. (2016). A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours. Anticancer Research, 36(2), 713-719.

@article{fa0ec4870e9841a79df97b205d807c18,

title = "A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours",

author = "N Fazio and R Buzzoni and E Baudin and L Antonuzzo and Hubner, \{R A\} and H Lahner and \{de Herder\}, W.W. and M Raderer and A Teule and J Capdevila and SK Libutti and MH Kulke and M Shah and D Dey and S Turri and P Aimone and C Massacesi and C Verslype",

year = "2016",

language = "Undefined/Unknown",

volume = "36",

pages = "713--719",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2",

}

Fazio, N, Buzzoni, R, Baudin, E, Antonuzzo, L, Hubner, RA, Lahner, H, de Herder, WW, Raderer, M, Teule, A, Capdevila, J, Libutti, SK, Kulke, MH, Shah, M, Dey, D, Turri, S, Aimone, P, Massacesi, C & Verslype, C 2016, 'A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours', Anticancer Research, vol. 36, no. 2, pp. 713-719.

TY - JOUR

T1 - A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

AU - Fazio, N

AU - Buzzoni, R

AU - Baudin, E

AU - Antonuzzo, L

AU - Hubner, R A

AU - Lahner, H

AU - de Herder, W.W.

AU - Raderer, M

AU - Teule, A

AU - Capdevila, J

AU - Libutti, SK

AU - Kulke, MH

AU - Shah, M

AU - Dey, D

AU - Turri, S

AU - Aimone, P

AU - Massacesi, C

AU - Verslype, C

PY - 2016

Y1 - 2016

M3 - Article

SN - 0250-7005

VL - 36

SP - 713

EP - 719

JO - Anticancer Research

JF - Anticancer Research

IS - 2

ER -